Suggested Topics within your search.
Showing 2,221 - 2,240 results of 2,982 for search 'show trial', query time: 0.06s Refine Results
  1. 2221

    Effects of tranquilization therapy in elderly patients suffering from chronic non-communicable diseases: A meta-analysis by Li Jing, Li Jing, Cui Yulan, Li Honggeng, Hou Xiaoxuan, Zhao Fang, Zhao Qing, Zhao Junlan, Lin Pengchao

    Published 2023-03-01
    “…This meta-analysis includes 16 randomized control trials spanning the years 2000 to 2022, using the data from 2224 patients. …”
    Get full text
    Article
  2. 2222

    Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis by Wenkai Zhang, Wenkai Zhang, Songbo Zhao, Songbo Zhao, Jipin Li, Jipin Li, Yihua Sun, Yihua Sun, Xiang Wang, Xiang Wang

    Published 2025-01-01
    “…More trials of direct comparisons are needed to inform clinical decision making with greater confidence.…”
    Get full text
    Article
  3. 2223

    Pain Management of Pediatric Musculoskeletal Injury in the Emergency Department: A Systematic Review by Sylvie Le May, Samina Ali, Christelle Khadra, Amy L. Drendel, Evelyne D. Trottier, Serge Gouin, Naveen Poonai

    Published 2016-01-01
    “…Due to heterogeneity of medications and routes of administration in the articles reviewed, an optimal analgesic cannot be recommended for all pain categories. Larger trials are required for further evaluation of analgesics, especially trials combining a nonopioid with an opioid agent or with a nonpharmacological intervention.…”
    Get full text
    Article
  4. 2224

    Efficacy and safety of the pulsed electromagnetic field in osteoarthritis: a meta-analysis by Ziying Wu, Xiang Ding, Guanghua Lei, Chao Zeng, Jie Wei, Jiatian Li, Hui Li, Tuo Yang, Yang Cui, Yilin Xiong, Yilun Wang, Dongxing Xie

    Published 2018-12-01
    “…Sensitivity analyses suggested that the exposure duration <=30 min per session exhibited better effects compared with the exposure duration >30 min per session. Three trials reported adverse events, and the combined results showed that there was no significant difference between PEMF and the sham group.Conclusions PEMF could alleviate pain and improve physical function for patients with knee and hand OA, but not for patients with cervical OA. …”
    Get full text
    Article
  5. 2225

    Vasospasm in Cerebral Inflammation by Michael Eisenhut

    Published 2014-01-01
    “…Another key factor in the pathogenesis of cerebral arterial vasospasm may be the reduced bioavailability of the vasodilator nitric oxide. Therapeutic trials in vasospasm related to inflammation in subarachnoid haemorrhage in humans showed a reduction of vasospasm through calcium antagonists, endothelin receptor antagonists, statins, and plasminogen activators. …”
    Get full text
    Article
  6. 2226

    Reduced tracheal stenosing effect of nintedanib in a patient with scarred posttraumatic tracheal stenosis and airflow limitation - a case report by Stefanie Klampfleitner, Andreas Fertl, Ositha Prinz, Martin Doerfler-Schalm, Dieter Munker, Markus O. Henke

    Published 2025-01-01
    “…Introduction: Nintedanib is a tyrosine kinase inhibitor and has been approved for the treatment of idiopathic pulmonary fibrosis (IPF) since 2020. In Clinical trials, the antifibrotic effect of nintedanib was shown. …”
    Get full text
    Article
  7. 2227

    ChatGPT for Univariate Statistics: Validation of AI-Assisted Data Analysis in Healthcare Research by Michael R Ruta, Tony Gaidici, Chase Irwin, Jonathan Lifshitz

    Published 2025-02-01
    “…ResultsChatGPT accurately performed data processing, categorization, and tabulation across all trials. For descriptive statistics, it provided accurate means, SDs, medians, and IQRs across all trials. …”
    Get full text
    Article
  8. 2228

    The efficacy and safety of indobufen in patients with ischemic cardiovascular or cerebrovascular diseases: systematic review and meta-analysis by Xiaolu Luo, Chenglu Lai, Tielong Chen

    Published 2025-01-01
    “…The results were presented as risk ratios (RR) with 95% confidence intervals (CI), and meta-analysis was performed using RevMan 5.3 and Stata 18.0 software.ResultsThe meta-analysis included 12 randomized controlled trials. Regarding safety, indobufen showed superior clinical outcomes compared to other antiplatelet agents regarding bleeding events, gastrointestinal adverse reactions, and overall adverse reactions, with these differences being more pronounced in cardiovascular diseases. …”
    Get full text
    Article
  9. 2229

    Chinese Herbal Medicine Combined with Intravitreal Antivascular Growth Factor Agents in Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta... by Su Xiaojuan, Li Xiaodong, Fu Zhongmei, Ye Hejiang

    Published 2022-01-01
    “…A total of 10 relevant trials with 743 patients were identified. The results showed that BCVA of the anti-VEGF + CHM group significantly improved at 3 months (P<0.00001), 6 months (P=0.008), and 12 months (P=0.01), and CMT significantly reduced at 1 month (P=0.02), 2 months (P=0.0009), 3 months (P<0.05), 6 months (P<0.0001), and 12 months (P<0.00001) compared with the anti-VEGF group alone. …”
    Get full text
    Article
  10. 2230

    Eye tracking to support assessment of patients with prolonged disorder of consciousness – a case series by Jan Johansson, Marika Möller, Kristina Franzon, Jonas Stenberg, Alison K. Godbolt

    Published 2025-01-01
    “…Results: Response data was obtained from 238 out of 288 trials. Eye-tracking data were obtained in median 89.6% of the trials (37.5–100%). …”
    Get full text
    Article
  11. 2231

    Perception of optical illusions in ungulates: insights from goats, sheep, guanacos and llamas by Caterina Berardo, Ruben Holland, Alina Schaffer, Alvaro Lopez Caicoya, Katja Liebal, Paola Valsecchi, Federica Amici

    Published 2024-05-01
    “…At the group level, there was a significant preference for the longer/larger food over the shorter/smaller one in control trials. Additionally, the whole group significantly preferred the food stick between two inward arrowheads over an identical one between two outward arrowheads in experimental trials of the Müller-Lyer task, and also preferred the food on the smaller circle over an identical one on the larger circle in the experimental trials of the Delboeuf task. …”
    Get full text
    Article
  12. 2232

    Educational Game "Sianting" to Improve Literacy and Anti-Bullying Education Using Problem-Solving Approach by Sabitul Kirom, Desy Anindia Rosyida

    Published 2024-11-01
    “…The results of limited trials in small groups get a percentage value of 89.37%, and extensive trials in large groups get a percentage value of 91.47%. …”
    Get full text
    Article
  13. 2233
  14. 2234

    Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis by Wenxia Lu, Sainan Li, Jingjing Li, Jianrong Wang, Rong Zhang, Yuqing Zhou, Qin Yin, Yuanyuan Zheng, Fan Wang, Yujing Xia, Kan Chen, Tong Liu, Jie Lu, Yingqun Zhou, Chuanyong Guo

    Published 2016-01-01
    “…Results. 577 cases of NAFLD/NASH in ten randomized controlled trials (RCTs) were included. The results of the meta-analysis showed that benefit changes in liver fat favored PUFA treatment, and it was also beneficial for GGT, but it was not significant on ALT, AST, TC, and LDL. …”
    Get full text
    Article
  15. 2235

    Molecular characterization and therapeutic insights into biofilm positive Staphylococcus aureus isolated from subclinical mastitis in dairy buffaloes by Muhammad Ijaz, Muhammad Umar Javed, Arslan Ahmed

    Published 2023-11-01
    “…Phylogenetic analysis of the studied isolates showed a high similarity with Egyptian and Indian icaA-positive S. aureus isolates. …”
    Get full text
    Article
  16. 2236

    Long Term Safety of Infliximab by Thomas F Schaible

    Published 2000-01-01
    “…In several placebo controlled, randomized clinical trials and open trials, 771 patients have been given infliximab (a further 192 received placebo). …”
    Get full text
    Article
  17. 2237

    Clinical Biology and Potential Use of Thrombopoietin by Russell Basser

    Published 2000-01-01
    “…However, one of these agents, interleukin-11, was successfully shown to reduce the incidence of severe thrombocytopenia in patients receiving dose-intensive chemotherapy, and has now received approval from the United States Food and Drug Administration for this purpose. Initial clinical trials of thrombopoietin, the central regulator of megakaryocytopoiesis and thrombopoiesis, and its analogues showed these agents to be the most potent stimulators of thrombopoiesis and to be associated with few adverse effects. …”
    Get full text
    Article
  18. 2238

    A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease by Yin-mei Fu, Ming Chen, Ai-jun Liao

    Published 2017-01-01
    “…Randomized controlled trials (rcts) or nonrandomized controlled trials (n-rcts) were included in this article to evaluate the role of ADA in the management of fistula in CD. …”
    Get full text
    Article
  19. 2239

    Screening and selection of drought-tolerant rainfed lowland rice seedlings based on early seedling vigor under Polyethylene Glycol-Induced Stress by Minerva L. Gaurana-Nuñez

    Published 2024-11-01
    “…Germination percentage and rate, root length, seedling vigour index, root and shoot dry weight were gathered. Data from two trials were combined and analyzed statistically for all growth parameters obtained. …”
    Get full text
    Article
  20. 2240

    Analgesic effect of intravesical lignocaine in urology surgery: A systematic review and meta-analysis by Ka T. Ng, Wei E. Lim, Wan Y. Teoh, Ahmad N. B. Fadzli, Mohd F. B. Z. Abidin

    “…Background and Aims: Recent trials showed that transurethral lignocaine for bladder irrigation provides excellent analgesic effects and can minimise catheter-related bladder discomfort. …”
    Get full text
    Article